Mitochondrial Complex V Atp Synthase Deficiency Nuclear Type 4a C5830480
A rare genetic disorder affecting mitochondria, the energy-producing structures in cells. It impairs energy generation, primarily affecting muscles, brain, and heart. Treatment focuses on symptom management and supportive care.
Key facts at a glance
- ICD-10
- E88.9
- ICD-11
- 5A00.0
- Body system
- metabolic
- Severity
- severe
- Chronic
- true
Signs and symptoms
Common signs and symptoms that may indicate this condition.
Developmental delay
(neurological)Fatigue or weight changes
(metabolic)Significant symptoms that substantially affect daily functioning.
Frequency: Common at all stages
Hypotonia
(musculoskeletal)Growth failure
(metabolic)Hearing loss
(ENT)Diagnosis and tests
How this condition is diagnosed and what test results mean.
Initial screening tests
Standard diagnostic workup
Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]
Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]
Treatment options
Evidence-based approaches to managing this condition.
First-line treatments
L-carnitine supplementation
L-carnitine helps transport fatty acids into mitochondria for energy production and may support cellular metabolism in complex V deficiency. Often combined with other mitochondrial support supplements.
Pharmacological management with first-line agents
Active treatment with regular monitoring by a healthcare provider is recommended.
Neurodevelopmental assessments
Regular pediatric neurology evaluations to monitor cognitive development, motor milestones, and detect early signs of neurological regression in type 4a deficiency.
Additional treatment options
Mitochondrial support nutrition plan
Comprehensive nutritional support including B-vitamins, alpha-lipoic acid, and adequate caloric intake to support mitochondrial function. Customized based on individual metabolic needs.
dietaryNeuropsychological support services
Cognitive rehabilitation and psychological support for patients and families dealing with mitochondrial disease-related developmental challenges and coping strategies.
psychologicalAcetyl-L-carnitine therapy
Antioxidant support therapy that may help protect mitochondrial function and reduce oxidative stress damage in complex V deficiency. Used as adjunctive treatment.
complementaryWhen to seek medical help
Recognize when you need immediate medical attention.
See a doctor within 24 hours
Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.
Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.
Frequently asked questions
Common questions about this topic.
What is Mitochondrial Complex V Atp Synthase Deficiency Nuclear Type 4a C5830480?
Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]
generalMedication Comparisons
Compare medications used to treat Mitochondrial Complex V Atp Synthase Deficiency Nuclear Type 4a C5830480. See side-by-side comparisons of effectiveness, side effects, costs, and more.
View Medication ComparisonsThis information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy